Biallelic loss of function variants in <scp><i>SYT2</i></scp> cause a treatable congenital onset presynaptic myasthenic syndrome
Sandra Donkervoort(Government of the United States of America), Carsten G. Bönnemann(National Institute of Neurological Disorders and Stroke), Tobias B. Haack(Technical University of Munich), Nicol C. Voermans(Radboud University Nijmegen), Joseph G. Gleeson(Children’s Institute), Maha S. Zaki(National Water Research Center), Veronka Horber(University Children's Hospital Tübingen), Victoria Biancavilla(National Institutes of Health Clinical Center), Tanya Lehky(National Institutes of Health), Rita Horváth(University of Cambridge), Katherine R. Chao(Broad Institute), Hasnaa M. Elbendary(National Human Genome Research Institute), Susan T. Iannaccone(Scottish Rite Hospital), Lucia Laugwitz(University Children's Hospital Tübingen), Matthew Nalls(National Institutes of Health), Corien C. Verschuuren‐Bemelmans(University Medical Center Groningen), Hanns Lochmüller(University of Ottawa), Payam Mohassel(Johns Hopkins University), Grace McMacken(Newcastle University), Molly Snyder(Medical City Children's Hospital), Henry Houlden(Queen Mary University of London), Reza Maroofian(University College London), A. Reghan Foley(National Institutes of Health), Erik‐Jan Kamsteeg(Radboud University Nijmegen), Minal S. Jain(National Institutes of Health Clinical Center), Annemarie Fock(University Medical Center Groningen), Riley M. McCarty(National Institutes of Health), Valentina Stanley(Children’s Institute), Chunyu Cai(The University of Texas Southwestern Medical Center)
Cited by 29
Related Papers
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Improving genetic diagnosis in Mendelian disease with transcriptome sequencing
|Science Translational Medicine|2017|809
De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
|Nature Genetics|2012|696
Mutations in dynamin 2 cause dominant centronuclear myopathy
|Nature Genetics|2005|462
High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies
|The American Journal of Human Genetics|2017|456